NewSquare Capital’s Opko Health OPK Stock Holding History

NewSquare Capital’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-150	Closed	-$326	–	807
2023 Q2	$326	Hold	150	–	–	﹤0.01%	723
2023 Q1	$219	Hold	150	–	–	﹤0.01%	786
2022 Q4	$188	Buy	+150	New	+$236	﹤0.01%	737

Other funds holding OPK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

NewSquare Capital's OPK Position: Q3 2023 in Review

NewSquare Capital sold out of Opko Health (OPK) in Q3 2023, closing a stake of 150 shares — an estimated $326 sold.

NewSquare Capital first reported a position in OPK in Q4 2022 and held it in 3 quarters. The position peaked at $326 in Q2 2023. 225 funds tracked by Wall St. Rank hold OPK as of Q3 2023.

NewSquare Capital reported no remaining Opko Health position as of Q3 2023 after selling out during the quarter.
NewSquare Capital sold 150 Opko Health shares in Q3 2023, an estimated $326.
NewSquare Capital first reported a position in Opko Health in Q4 2022 and held it in 3 quarters.
NewSquare Capital's Opko Health position peaked at $326 in Q2 2023.
225 funds tracked by Wall St. Rank held Opko Health as of Q3 2023.

Based on NewSquare Capital's 13F filing for Q3 2023, filed 3 Nov 2023.